Cliff Asness's AVBP Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 11,475 shares of ArriVent BioPharma, Inc. (AVBP) worth $230,878, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Cliff Asness has maintained this position in AVBP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 14,336 shares. Largest reduction occurred in Q1 2025, reducing 8,868 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ArriVent BioPharma (AVBP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ArriVent BioPharma (AVBP) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -348 | Reduce 2.94% | 11,475 | $20.12 |
| Q3 2025 | -2,513 | Reduce 17.53% | 11,823 | $18.45 |
| Q2 2025 | +14,336 | New Buy | 14,336 | $21.77 |
| Q1 2025 | -8,868 | Sold Out | 0 | $0.00 |
| Q4 2024 | +211 | Add 2.44% | 8,868 | $26.64 |
| Q3 2024 | +8,657 | New Buy | 8,657 | $23.50 |
Cliff Asness's ArriVent BioPharma Investment FAQs
Cliff Asness first purchased ArriVent BioPharma, Inc. (AVBP) in Q3 2024, acquiring 8,657 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ArriVent BioPharma, Inc. (AVBP) for 6 quarters since Q3 2024.
Cliff Asness's largest addition to ArriVent BioPharma, Inc. (AVBP) was in Q2 2025, adding 14,336 shares worth $312,095.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 11,475 shares of ArriVent BioPharma, Inc. (AVBP), valued at approximately $230,878.
As of the Q4 2025 filing, ArriVent BioPharma, Inc. (AVBP) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in ArriVent BioPharma, Inc. (AVBP) was 14,336 shares, as reported at the end of Q2 2025.